Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Earlier initiation of diabetes medications can lead to reduced heart disease risk in type 2 patients.
Read More »Cardiovascular Disease Risk Reduction
Relationship Between Risk Factors, Age, and Mortality in Type 1 Diabetes Patients
Management of non-glycemic cardiovascular disease risk factors may have increasing benefits in an aging type 1 diabetes patient population with long-term hyperglycemia.
Read More »Cause of Low Mortality Rate from Coronary Heart Disease
Increase in BMI and A1c leads to coronary issues.
Read More »Diabetic Peripheral Neuropathy In Young Adults
Long-term uncontrolled glycemic levels primary cause of complication.
Read More »Beta Blockers And the Risk of CV Events in Type 2 Diabetes
Beta-blocker use in patients with T2DM and established CV risk factors associated with increased risk of CV events and severe hypoglycemia, according to recent study.
Read More »CDC: 100 Million Have Diabetes or Prediabetes
The growth of diabetes in the United States may be slowing, but it is still increasing. Just how bad can it get?
Read More »Lipid-Lowering Effect of Extra Virgin Olive Oil and Atorvastatin in Type 2 Diabetes
Extra virgin olive oil, like statins, promotes lipid lowering in people with diabetes who have dyslipidemia.
Read More »Link Between Serum Bilirubin and Diabetic Retinopathy in Type 2 Diabetes Patients
Serum bilirubin is inversely correlated with diabetic retinopathy predicting progression of retinopathy over time.
Read More »Even More Protection for the Kidneys With An SGLT-2 Inhibitor (And a comment from George Bakris, MD)
New data from the EMPA-REG-OUTCOME study provide more evidence of the renoprotective effects of empagliflozin in patients with type 2 and cardiovascular disease.
Read More »The Link Between Depression and Gestational Diabetes
Study finds increased risk during and after pregnancy
Read More »